IP Library Granted Patent US 9,833,528
Granted Patent B2
US 9,833,528 · App. 14/851,178 · Granted Dec 5, 2017

Targeted enzymatic degradation of quorum-sensing peptides

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,833,528
App. No.
14/851,178
Granted
Dec 5, 2017
Kind
B2
Abstract

Methods and compositions for the treatment of biofilms and/or the inhibition of biofilm formation. In one embodiment, a biofilm is treated and/or biofilm formation is inhibited by a method comprising contacting a biofilm or a surface with a bifunctional ligand comprising a quorum-sensing-peptide-binding region and a protease-binding region, whereby the biofilm is treated and/or biofilm formation on the surface is inhibited.

Claims (25)

1. A bifunctional ligand, comprising:

a quorum-sensing-molecule-binding region adapted to bind one or more of an acylated homoserine lactone (AHL), an autoinducing peptide (AIP), AI-2 (a furanosyl borate diester), a γ-butyrolactone, and a competence stimulating peptide (CSP); and

a protease-binding region chemically linked to the quorum-sensing-molecule-binding region, wherein the protease-binding region is adapted to bind a lactonase.

2. The bifunctional ligand of claim 1 , wherein the quorum-sensing-molecule-binding region comprises a quorum-sensing molecule receptor or a quorum-sensing molecule receptor fragment.

3. The bifunctional ligand of claim 1 , wherein the quorum-sensing-molecule-binding region comprises an antibody or an antibody fragment that binds a quorum-sensing molecule.

4. The bifunctional ligand of claim 1 , further comprising a peptide linker between the quorum-sensing-molecule-binding region and the protease-binding region.

5. A composition comprising a bifunctional ligand of claim 1 and a pharmaceutically acceptable carrier.

6. The composition of claim 5 , wherein the composition is formulated as a liquid, gel, or foam.

7. The composition of claim 5 , wherein the composition further comprises an antibiotic.

8. The composition of claim 5 , wherein the composition further comprises a protease.

9. A kit comprising the composition of claim 5 .

10. The kit of claim 9 , further comprising an antibiotic.

11. The kit of claim 9 , further comprising a protease.

12. A dressing for treating a wound, comprising:

a distribution manifold comprising an open-cell foam; and

a bifunctional ligand disposed on a surface of the distribution manifold and comprising a quorum-sensing-molecule-binding region chemically linked to a protease-binding region.

13. The dressing of claim 12 , further comprising a sealing member adapted to be positioned over the distribution manifold and the wound to create a sealed environment.

14. The dressing of claim 13 , further comprising a reduced-pressure source adapted to be in fluid communication with the sealed environment.

15. A system for treating a tissue site, comprising:

a distribution manifold adapted to be placed over the tissue site;

a sealing member for covering the distribution manifold and for creating a sealed environment around the tissue site;

a reduced-pressure source adapted to be in fluid communication with the sealed environment; and

a fluid-delivery source adapted to supply a solution comprising a bifunctional ligand comprising a quorum-sensing-molecule-binding region chemically linked to a protease-binding region.

16. The system of claim 15 , wherein the distribution manifold comprises a non-woven fabric material.

17. The system of claim 15 , wherein the distribution manifold comprises a woven fabric material.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066430/0333 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 25, 2023
From: KCI LICENSING, INC.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 064718/0544 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Nov 7, 2019
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: KCI USA, INC.; KCI LICENSING, INC.
Reel/Frame 050966/0547 →
RELEASE OF SECURITY INTEREST REEL/FRAME 040098/0268 Recorded Feb 8, 2017
From: WILMINGTON TRUST
To: KCI USA, INC.
Reel/Frame 041666/0320 →
LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 7, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040291/0237 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 21, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040098/0268 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 22, 2015
From: ALARCON, RODOLFO M.; MCNULTY, AMY K.
To: KCI LICENSING, INC.
Reel/Frame 036624/0340 →